Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
See Grinberg and Heinsen (doi:10.1093/brain/awx261) for a scientific commentary on this article. Clinical evidence suggests that aberrant tau accumulation in the locus coeruleus and noradrenergic dysfunction may be a critical early step in Alzheimer’s disease progression. Yet, an accurate preclinical model of these phenotypes that includes early pretangle tau accrual in the locus coeruleus, loss of locus coeruleus innervation and deficits locus coeruleus/norepinephrine modulated behaviours, does not exist, hampering the identification of underlying mechanisms and the development of locus coeruleus-based therapies. Here, a transgenic rat (TgF344-AD) expressing disease-causing mutant amyloid precursor protein (APPsw) and presenilin-1 (PS1ΔE9) was characterized for histological and behavioural signs of locus coeruleus dysfunction reminiscent of mild cognitive impairment/early Alzheimer’s disease. In TgF344-AD rats, hyperphosphorylated tau was detected in the locus coeruleus prior to accrual in the medial entorhinal cortex or hippocampus, and tau pathology in the locus coeruleus was negatively correlated with noradrenergic innervation in the medial entorhinal cortex. Likewise, TgF344-AD rats displayed progressive loss of hippocampal norepinephrine levels and locus coeruleus fibres in the medial entorhinal cortex and dentate gyrus, with no frank noradrenergic cell body loss. Cultured mouse locus coeruleus neurons expressing hyperphosphorylation-prone mutant human tau had shorter neurites than control neurons, but similar cell viability, suggesting a causal link between pretangle tau accrual and altered locus coeruleus fibre morphology. TgF344-AD rats had impaired reversal learning in the Morris water maze compared to their wild-type littermates, which was rescued by chemogenetic locus coeruleus activation via designer receptors exclusively activated by designer drugs (DREADDs). Our results indicate that TgF344-AD rats uniquely meet several key criteria for a suitable model of locus coeruleus pathology and dysfunction early in Alzheimer’s disease progression, and suggest that a substantial window of opportunity for locus coeruleus/ norepinephrine-based therapeutics exists.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The brain noradrenergic system is also critical for cognition and noradrengergic dysfunction is a critical early step in AD progression 249.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [249]
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194
The locus coeruleus and noradrenergic modulation of cognition
Sara, S. J. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2573 · Cited by 1,848
The efficiency of systematic sampling in stereology—reconsidered
GUNDERSEN, H. J. G., JENSEN, E. B. V., KIÊU, K., & NIELSEN, J. (1999) · Journal of Microscopy · doi:10.1046/j.1365-2818.1999.00457.x · Cited by 1,317
Augustinack, J. C., Schneider, A., Mandelkow, E.-M., & Hyman, B. T. (2002) · Acta Neuropathologica · doi:10.1007/s004010100423 · Cited by 998
The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies)
Amaral, D. G., Scharfman, H. E., & Lavenex, P. (2007) · Progress in brain research · doi:10.1016/s0079-6123(07)63001-5 · Cited by 888
Al-Atrache, Z., Cader, A., & Appelt, D. M. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.894 · Cited by 765
Allen, B., Ingram, E., Takao, M., Smith, M. J., Jakes, R., Virdee, K., Yoshida, H., Holzer, M., Craxton, M., Emson, P. C., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09340.2002 · Cited by 751
Viral-genetic tracing of the input-output organization of a central noradrenaline circuit
Schwarz, L. A., Miyamichi, K., Gao, X. J., Beier, K. T., Weissbourd, B., DeLoach, K. E., Ren, J., Ibanes, S., Malenka, R. C., Kremer, E. J., et al. (2015) · Nature · doi:10.1038/nature14600 · Cited by 744
CRH Engagement of the Locus Coeruleus Noradrenergic System Mediates Stress-Induced Anxiety
McCall, J. G., Al-Hasani, R., Siuda, E. R., Hong, D. Y., Norris, A. J., Ford, C. P., & Bruchas, M. R. (2015) · Neuron · doi:10.1016/j.neuron.2015.07.002 · Cited by 666
Cohen, R. M., Rezai-Zadeh, K., Weitz, T. M., Rentsendorj, A., Gate, D., Spivak, I., Bholat, Y., Vasilevko, V., Glabe, C. G., Breunig, J. J., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3672-12.2013 · Cited by 531
Self-citationYassa, M. A., Stark, S. M., Bakker, A., Albert, M. S., Gallagher, M., & Stark, C. E. L. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.03.040 · Cited by 523
Chan‐Palay, V., & Asan, E. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902870308 · Cited by 495
The Locus Coeruleus: Essential for Maintaining Cognitive Function and the Aging Brain
Mather, M., & Harley, C. W. (2016) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2016.01.001 · Cited by 492
Cell loss in the locus coeruleus in senile dementia of Alzheimer type
Tomlinson, B. E., Irving, D., & Blessed, G. (1981) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(81)90031-9 · Cited by 453
Theofilas, P., Ehrenberg, A. J., Dunlop, S., Di Lorenzo Alho, A. T., Nguy, A., Leite, R. E. P., Rodriguez, R. D., Mejia, M. B., Suemoto, C. K., Ferretti-Rebustini, R. E. D. L., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.2362 · Cited by 416
High-throughput mapping of single-neuron projections by sequencing of barcoded RNA
Kebschull, J. M., Garcia da Silva, P., Reid, A. P., Peikon, I. D., Albeanu, D. F., & Zador, A. M. (2016) · Neuron · doi:10.1016/j.neuron.2016.07.036 · Cited by 376
Heneka, M. T., Ramanathan, M., Jacobs, A. H., Dumitrescu-Ozimek, L., Bilkei-Gorzo, A., Debeir, T., Sastre, M., Galldiks, N., Zimmer, A., Hoehn, M., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4236-05.2006 · Cited by 305
Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease
Kelly, S. C., He, B., Perez, S. E., Ginsberg, S. D., Mufson, E. J., & Counts, S. E. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0411-2 · Cited by 286
Small, S. A., Chawla, M. K., Buonocore, M., Rapp, P. R., & Barnes, C. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400285101 · Cited by 280
Vazey, E. M., & Aston-Jones, G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310025111 · Cited by 279
Neural reserve, neuronal density in the locus ceruleus, and cognitive decline
Wilson, R. S., Nag, S., Boyle, P. A., Hizel, L. P., Yu, L., Buchman, A. S., Schneider, J. A., & Bennett, D. A. (2013) · Neurology · doi:10.1212/wnl.0b013e3182897103 · Cited by 274
Afferent and efferent connections of the A5 noradrenergic cell group in the rat
Byrum, C. E., & Guyenet, P. G. (1987) · Journal of Comparative Neurology · doi:10.1002/cne.902610406 · Cited by 263
Heneka, M. T., Galea, E., Gavriluyk, V., Dumitrescu-Ozimek, L., Daeschner, J., O'Banion, M. K., Weinberg, G., Klockgether, T., & Feinstein, D. L. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02434.2002 · Cited by 259
Where, when, and in what form does sporadic Alzheimerʼs disease begin?
Braak, H., & Del Tredici, K. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835a3432 · Cited by 257
Szot, P., White, S. S., Greenup, J. L., Leverenz, J. B., Peskind, E. R., & Raskind, M. A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4265-05.2006 · Cited by 248
Ehrenberg, A. J., Nguy, A. K., Theofilas, P., Dunlop, S., Suemoto, C. K., Di Lorenzo Alho, A. T., Leite, R. P., Diehl Rodriguez, R., Mejia, M. B., Rüb, U., et al. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12387 · Cited by 236
Hart, A. D., Wyttenbach, A., Hugh Perry, V., & Teeling, J. L. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.11.006 · Cited by 230
Modeling Alzheimer’s disease in transgenic rats
Do Carmo, S., & Cuello, A. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-37 · Cited by 206
Functional Consequences of Locus Coeruleus Degeneration in Alzheimers Disease
Weinshenker, D. (2008) · Current Alzheimer Research · doi:10.2174/156720508784533286 · Cited by 181
Self-citationFeinstein, D. L., Kalinin, S., & Braun, D. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13447 · Cited by 176
Woerman, A. L., Aoyagi, A., Patel, S., Kazmi, S. A., Lobach, I., Grinberg, L. T., McKee, A. C., Seeley, W. W., Olson, S. H., & Prusiner, S. B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616344113 · Cited by 176
Kori, M., Aydın, B., Ünal, S., Arğa, K. Y., & Kazan, D. (2016) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0106 · Cited by 176
Relevance of Transgenic Mouse Models to Human Alzheimer Disease
Morrissette, D. A., Parachikova, A. I., Green, K. N., & LaFerla, F. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800030200 · Cited by 167
Hagena, H., Hansen, N., & Manahan-Vaughan, D. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhv330 · Cited by 159
Petry, F. R., Pelletier, J., Bretteville, A., Morin, F., Calon, F., Hébert, S. S., Whittington, R. A., & Planel, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094251 · Cited by 158
Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
Chalermpalanupap, T., Kinkead, B. L., Hu, W. T., Kummer, M. P., Hammerschmidt, T., Heneka, M. T., Weinshenker, D., & Levey, A. I. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt175 · Cited by 154
Self-citationJardanhazi‐Kurutz, D., Kummer, M. P., Terwel, D., Vogel, K., Dyrks, T., Thiele, A., & Heneka, M. T. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.02.001 · Cited by 145
Tau: The Center of a Signaling Nexus in Alzheimer's Disease
Khan, S. S., & Bloom, G. S. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00031 · Cited by 144
Gasparini, L., Anthony Crowther, R., Martin, K. R., Berg, N., Coleman, M., Goedert, M., & Spillantini, M. G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.03.002 · Cited by 133
Hammerschmidt, T., Kummer, M. P., Terwel, D., Martinez, A., Gorji, A., Pape, H., Rommelfanger, K. S., Schroeder, J. P., Stoll, M., Schultze, J. L., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.013 · Cited by 121
Self-citationLocus coeruleus at asymptomatic early and middle Braak stages of neurofibrillary tangle pathology
Andrés‐Benito, P., Fernández‐Dueñas, V., Carmona, M., Escobar, L. A., Torrejón-Escribano, B., Aso, E., Ciruela, F., & Ferrer, I. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12386 · Cited by 120
Baron, R., Babcock, A. A., Nemirovsky, A., Finsen, B., & Monsonego, A. (2014) · Aging Cell · doi:10.1111/acel.12210 · Cited by 118
Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia
Song, C., Fan, X., Exeter, C. J., Hess, E. J., & Jinnah, H. A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.009 · Cited by 118
The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer’s disease
Kalinin, S., Polak, P. E., Lin, S. X., Sakharkar, A. J., Pandey, S. C., & Feinstein, D. L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.04.012 · Cited by 116
Scuderi, C., Stecca, C., Valenza, M., Ratano, P., Bronzuoli, M. R., Bartoli, S., Steardo, L., Pompili, E., Fumagalli, L., Campolongo, P., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.376 · Cited by 114
Hansen, N., & Manahan‐Vaughan, D. (2014) · Cerebral Cortex · doi:10.1093/cercor/bht429 · Cited by 106
Hansen, N., & Manahan‐Vaughan, D. (2015) · Hippocampus · doi:10.1002/hipo.22436 · Cited by 92
Designer Receptors Enhance Memory in a Mouse Model of Down Syndrome
Fortress, A. M., Hamlett, E. D., Vazey, E. M., Aston‐Jones, G., Cass, W. A., Boger, H. A., & Granholm, A. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2658-14.2015 · Cited by 88
Haglund, M., Sjöbeck, M., & Englund, E. M. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00725.x · Cited by 88
Xiao, Z., Deng, P., Rojanathammanee, L., Yang, C., Grisanti, L. A., Permpoonputtana, K., Weinshenker, D., Doze, V. A., Porter, J. E., & Lei, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806760200 · Cited by 81
Self-citationEar2 Deletion Causes Early Memory and Learning Deficits in APP/PS1 Mice
Kummer, M. P., Hammerschmidt, T., Martínez, A., Terwel, D., Eichele, G., Witten, A., Figura, S., Stoll, M., Schwartz, S., Pape, H., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4027-13.2014 · Cited by 77
Self-citationMemory deficits correlate with tau and spine pathology in P 301 S MAPT transgenic mice
Xu, H. W., Rösler, T. W., Carlsson, T., de Andrade, A., Bruch, J., Höllerhage, M., Oertel, W. H., & Höglinger, G. U. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12160 · Cited by 68
Mohs, R. C., Shiovitz, T. M., Tariot, P. N., Porsteinsson, A. P., Baker, K. D., & Feldman, P. D. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181aad585 · Cited by 64
Bardou, I., Kaercher, R. M., Brothers, H. M., Hopp, S. C., Royer, S. E., & Wenk, G. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.006 · Cited by 62
Effect of reversible inactivation of locus ceruleus on spatial reference and working memory
Khakpour-Taleghani, B., Lashgari, R., Motamedi, F., & Naghdi, N. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.001 · Cited by 59
Selective noradrenaline depletion impairs working memory and hippocampal neurogenesis
Coradazzi, M., Gulino, R., Fieramosca, F., Falzacappa, L. V., Riggi, M., & Leanza, G. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.012 · Cited by 56
The Treatment of Primary Orthostatic Hypotension
Hale, G. M., Valdes, J., & Brenner, M. J. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028016689264 · Cited by 51
Automated measurement of nerve fiber density using line intensity scan analysis
Sathyanesan, A. G., Ogura, T., & Lin, W. (2012) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2012.02.019 · Cited by 45
Neurochemical characteristics of aluminum-induced neurofibrillary degeneration in rabbits
Beal, M. F., Mazurek, M. F., Ellison, D. W., Kowall, N. W., Solomon, P. R., & Pendlebury, W. W. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90061-4 · Cited by 45
Frequency analysis of catecholamine axonal morphology in human brain
Booze, R. M., Mactutus, C. F., Gutman, C. R., & Davis, J. N. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90198-8 · Cited by 32
Age-dependent changes in noradrenergic innervations of the frontal cortex in F344 rats
Ishida, Y., Shirokawa, T., Miyaishi, O., Komatsu, Y., & Isobe, K. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00203-7 · Cited by 27
Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior
Fentress, H. M., Klar, R., Krueger, J. J., Sabb, T. R., Redmon, S. N., Wallace, N. M., Shirey-Rice, J. K., & Hahn, M. K. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12084 · Cited by 23
Taşdelen, B. İ., Karakaya, E., & Öztop, D. B. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0155 · Cited by 20
Mravec, B., Lejavová, K., Vargovič, P., Ondičová, K., Horváthová, Ľ., Novák, P., Manz, G., Filipčík, P., Novák, M., & Květňanský, R. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0482-1 · Cited by 19
Atomoxetine accelerates attentional set shifting without affecting learning rate in the rat
Totah, N. K. B., Logothetis, N. K., & Eschenko, O. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4028-5 · Cited by 18
Frequency analysis of catecholamine axonal morphology in human brain
Booze, R. M., Mactutus, C. F., Gutman, C. R., & Davis, J. N. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90197-7 · Cited by 15
Hippocampal Laminar Distribution of Tau Relates to Alzheimer's Disease and Age of Onset
Seifan, A., Marder, K. S., Mez, J., Noble, J. M., Cortes, E. P., Vonsattel, J. P., & Honig, L. S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140279 · Cited by 12
Turnbull, M. T., & Coulson, E. J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160805 · Cited by 11
Cited by
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
Betts, M. J., Kirilina, E., Otaduy, M. C. G., Ivanov, D., Acosta-Cabronero, J., Callaghan, M. F., Lambert, C., Cardenas-Blanco, A., Pine, K., Passamonti, L., et al. (2019) · Brain · doi:10.1093/brain/awz193 · Cited by 365
“In animal models, lesions of the LC have been shown to exacerbate tau and amyloid-b plaque deposition, leading to depletion of noradrenaline in LC target regions and impaired cognitive function (Heneka, 2006; Kalinin et al., 2006, 2012; Jardanhazi-Kurutz et al., 2010; Chalermpalanupap et al., 2017; Rorabaugh et al., 2…”
BackgroundLong Road to Ruin: Noradrenergic Dysfunction in Neurodegenerative Disease
Weinshenker, D. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.01.010 · Cited by 323
“, chemogenetic/optogenetic facilitation, NE prodrugs/agonists/reuptake inhibitors, aerobic exercise, environmental enrichment) could be of benefit, as already shown for animal models and in some human studies [16,17,21,30,42,130,131].”
InfluentialSelf-citationYan, Z., & Rein, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01092-3 · Cited by 300
“The brain noradrenergic system is also critical for cognition and noradrenergic dysfunction is a critical early step in AD progression [249].”
BackgroundXiao, W., Su, J., Gao, X., Yang, H., Weng, R., Ni, W., & Gu, Y. (2022) · Microbiome · doi:10.1186/s40168-022-01255-6 · Cited by 252
“Hippocampal changes underlie the cognitive decline in chronological aging and CNS diseases like AD [54, 55].”
BackgroundJacobs, H. I. L., Becker, J. A., Kwong, K., Engels-Domínguez, N., Prokopiou, P. C., Papp, K. V., Properzi, M., Hampton, O. L., d’Oleire Uquillas, F., Sanchez, J. S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj2511 · Cited by 228
Metadata
- Authors
- Rorabaugh, J. M., Chalermpalanupap, T., Botz-Zapp, C. A., Fu, V. M., Lembeck, N. A., Cohen, R. M., & Weinshenker, D.
- Affiliations
- Emory University (US)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-09-25
- Volume
- 140
- Issue
- 11
- Pages
- 3023-3038
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC5841201
- OpenAlex
- W2760256027
- Cited by
- 227
- References
- 72
- Citations by year
- 2026: 24 · 2025: 25 · 2024: 39 · 2023: 20 · 2022: 45 · 2021: 26 · 2020: 18 · 2019: 14 · 2018: 13 · 2017: 3
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Brain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AG0476670, NS007480)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- locus coeruleus, Alzheimer's disease, reversal learning, tau hyperphosphorylation, noradrenergic dysfunction, norepinephrine, TgF344-AD rats, medial entorhinal cortex, DREADD, chemogenetic activation, mild cognitive impairment, preclinical models
- MeSH terms
- Alzheimer Disease, Animals, Cells, Cultured, Disease Models, Animal, Female, Locus Coeruleus, Male, Rats, Inbred F344, Reversal Learning, tau Proteins, Maze Learning, Rats, Rats, Transgenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.